Loading...
View the Webinar

Diversion oversight is expanding across health systems, yet teams are frequently stretched thin, spending...
Learn MoreIn the final session of the 2026 Diversion Symposium, Bluesight invited current users of...
Learn MoreDuring the 2026 Diversion Symposium, Dr. Steve Leuck, a clinical pharmacist with 39 years...
Learn MoreDuring their session at the 2026 Bluesight Diversion Symposium, Lauren Forni and Muzzy Rizvi...
Learn MoreThe DEA intentionally avoids giving an exact number or percentage to define “significant loss.”...
Learn More